{"abstract": "Henri Termeer of Genzyme told Le Figaro that he was not against Sanofi-Aventis\u2019s $18.5 billion takeover offer in principle, he just thinks it should be higher.", "web_url": "https://dealbook.nytimes.com/2010/11/26/genzymes-chief-chides-sanofi-on-price/", "snippet": "Henri Termeer of Genzyme told Le Figaro that he was not against Sanofi-Aventis\u2019s $18.5 billion takeover offer in principle, he just thinks it should be higher.", "lead_paragraph": "Henri Termeer, chairman and chief executive of the American biotech company Genzyme, told Le Figaro in an interview that while he was not against Sanofi-Aventis\u2019s $18.5 billion takeover offer in principle, he thinks it should be higher.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Genzyme\u2019s Chief Chides Sanofi on Price", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2010-11-26T10:59:25+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Chris V. Nicholson", "person": [{"firstname": "Chris", "middlename": "V.", "lastname": "Nicholson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/e558a593-93df-5994-a3a0-0e484bacc6fa", "word_count": 194, "uri": "nyt://article/e558a593-93df-5994-a3a0-0e484bacc6fa"}